Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 23, 1988 - Issue 9
Submit an article Journal homepage
23
Views
26
CrossRef citations to date
0
Altmetric
Original Article

The Effect of Omeprazole or Ranitidine Treatment on 24-Hour Esophageal Acidity in Patients with Reflux Esophagitis

M. Ruth Depts. of Otorhinolaryngology and Surgery, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden; Dept. of Otorhinolaryngology, Regional Hospital, örebro, Sweden
,
H. Enbom Depts. of Otorhinolaryngology and Surgery, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden; Dept. of Otorhinolaryngology, Regional Hospital, örebro, Sweden
,
L. Lundell Depts. of Otorhinolaryngology and Surgery, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden; Dept. of Otorhinolaryngology, Regional Hospital, örebro, Sweden
,
H. Lönroth Depts. of Otorhinolaryngology and Surgery, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden; Dept. of Otorhinolaryngology, Regional Hospital, örebro, Sweden
,
N. Sandberg Depts. of Otorhinolaryngology and Surgery, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden; Dept. of Otorhinolaryngology, Regional Hospital, örebro, Sweden
&
S. Sandmark Depts. of Otorhinolaryngology and Surgery, Sahlgren's Hospital, University of Gothenburg, Gothenburg, Sweden; Dept. of Otorhinolaryngology, Regional Hospital, örebro, Sweden
Pages 1141-1146 | Received 28 Apr 1988, Accepted 29 Jul 1988, Published online: 08 Jul 2009

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

T. L. Venables, R. D. Newland, A. C. Patel, J. Hole, C. Wilcock & M. L. Turbitt. (1997) Omeprazole 10 Milligrams Once Daily, Omeprazole 20 Milligrams Once Daily, or Ranitidine 150 Milligrams Twice Daily, Evaluated as Initial Therapy for the Relief of Symptoms of Gastro-oesophageal Reflux Disease in General Practice. Scandinavian Journal of Gastroenterology 32:10, pages 965-973.
Read now
G. Van Den Boom, P. M. M. Y. H. Go, W. Hameeteman, B. Dallemagne & A. J. H. A. Ament. (1996) Cost Effectiveness of Medical versus Surgical Treatment in Patients with Severe or Refractory Gastroesophageal Reflux Disease in The Netherlands. Scandinavian Journal of Gastroenterology 31:1, pages 1-9.
Read now
L. Sterk Laursen, T. Havelund, S. Bondesen, J. Hansen, G. Sanchez, E. Sebelin, C. Fenger & K. Lauritsen. (1995) Omeprazole in the Long-Term Treatment of Gastro-oesophageal Reflux Disease: A Double-Blind Randomized Dose-Finding Study. Scandinavian Journal of Gastroenterology 30:9, pages 839-846.
Read now
J. Dent. (1994) Roles of Gastric Acid and pH in the Pathogenesis of Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 29:sup201, pages 55-61.
Read now
T. Lind, C. Cederberg, J.-P. Idström, H. Lönroth, L. Olbe & L. Lundell. (1991) 24-Hour Intragastric Acidity and Plasma Gastrin during Long-Term Treatment with Omeprazole or Ranitidine in Patients with Reflux Esophagitis. Scandinavian Journal of Gastroenterology 26:6, pages 620-626.
Read now
L. Lundell, L. Backman, P. Ekström, L.-K. Enander, S. Falkmer, O. Fausa, L. Grimelius, N. Havu, T. Lind, H. Lönroth, S. Sandmark, B. Sandzén, P. Unge & I. H. Westin. (1991) Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine. Scandinavian Journal of Gastroenterology 26:3, pages 248-256.
Read now

Articles from other publishers (20)

Tessa F. Ververs, Anne-Fleur H. Lobbezoo, Monique G. Hobbelink & Arthur J. Braat. (2023) Patient Preparation with Esomeprazole Is Comparable to Ranitidine in Meckel Diverticulum Scintigraphy. Journal of Nuclear Medicine Technology, pages jnmt.123.265558.
Crossref
Joshua A. Sloan & Philip O. Katz. (2021) Proton Pump Inhibitors in 2021: Pros, Cons, and Everything in Between. Foregut: The Journal of the American Foregut Society 1:2, pages 145-151.
Crossref
Mohammad Yaghoobi, Sara Padol, Yuhong Yuan & Richard H. Hunt. (2010) Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. European Journal of Gastroenterology & Hepatology 22:5, pages 583-590.
Crossref
Yoshikazu Kinoshita, Takeaki Kobayashi, Mototsugu Kato, Kan Asahina, Ken Haruma, Tomohiko Shimatani, Shuji Inoue, Teppei Kabemura, Susumu Kurosawa, Hajime Kuwayama, Kiyoshi Ashida, Michiaki Hirayama, Satoshi Kiyama, Munemitsu Yamamoto, Junichi Suzuki, Hiroyuki Suzuki, Katsuhiko Matsumoto & Masaru Aoshima. (2006) The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. Journal of Gastroenterology 41:6, pages 554-561.
Crossref
Barbezat, Schlup & Lubcke. (2001) Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures. Alimentary Pharmacology & Therapeutics 13:8, pages 1041-1045.
Crossref
Peter J Kahrilas, Brian M Fennerty & Bo Joelsson. (1999) High- Versus Standard-Dose Ranitidine for Control of Heartburn in Poorly Responsive Acid Reflux Disease: A Prospective, Controlled Trial. American Journal of Gastroenterology 94:1, pages 92-97.
Crossref
J.-P. Galmiche, P. Barthelemy & B. Hamelin. (1997) Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Alimentary Pharmacology and Therapeutics 11:4, pages 765-773.
Crossref
R. Carlsson, J.‐P. Galmiche, J. Dent, L. Lundell & L. Frison. (2003) Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta‐analysis of long‐term omeprazole trials. Alimentary Pharmacology & Therapeutics 11:3, pages 473-482.
Crossref
Masashi Yoshida, Yoshihide Otani, Hideki Ishikawa, Naoki Igarashi, Koji Fujita, Noritaka Hayashi, Hiroto Ishizuka, Tetsuro Kubota, Koichiro Kumai & Masaki Kitajima. (1996) Administration of a histamine2-receptor antagonist in reflux esophagitis after gastrectomy: simultaneous pH monitoring of the esophagus and residual stomach. Current Therapeutic Research 57:11, pages 869-877.
Crossref
D. JASPERSEN, H. SCHWACHA, W. SCHORR, M. BRENNENSTUHL, C. RASCHKA & CH HAMMAR. (2008) OMEPRAZOLE AND COMPLICATED GASTRO‐OESOPHAGEAL REFLUX DISEASE. Journal of Gastroenterology and Hepatology 11:10, pages 900-902.
Crossref
I. David BoughJr.Jr., Robert Thayer Sataloff, Donald O. Castell, James R. Hills, R. Matthew Gideon & Joseph R. Spiegel. (1995) Gastroesophageal reflux laryngitis resistant to omeprazole therapy. Journal of Voice 9:2, pages 205-211.
Crossref
I. C. E. Wesdorp, W. Dekker & H. P. M. Festen. (1993) Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis. Digestive Diseases and Sciences 38:12, pages 2287-2293.
Crossref
G. BIANCHI PORRO & F. PACE. (2009) Rationale and efficacy of medical therapy for gastroesophageal reflux disease. Journal of Internal Medicine 234:4, pages 387-396.
Crossref
M. Ruth, S. Carlsson, I. Månsson, U. Bengtsson & N. Sandberg. (2008) Scintigraphic detection of gastro‐pulmonary aspiration in patients with respiratory disorders. Clinical Physiology 13:1, pages 19-33.
Crossref
J. RUSSELL, W. C. ORR, T. WILSON & A. L. FINN. (2007) Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux. Alimentary Pharmacology & Therapeutics 5:6, pages 621-630.
Crossref
Stephen j. Sontag. (1990) The Medical Management of Reflux Esophagitis. Gastroenterology Clinics of North America 19:3, pages 683-712.
Crossref
J.S. de Caestecker & R.C. Heading. (1990) Esophageal pH Monitoring. Gastroenterology Clinics of North America 19:3, pages 645-669.
Crossref
E M Brett. (1990) "It isn't epilepsy is it, doctor?".. BMJ 300:6740, pages 1604-1606.
Crossref
T V Taylor & S Holt. (1990) Antireflux surgery.. BMJ 300:6740, pages 1603-1604.
Crossref
L. LUNDELL, L. BACKMAN, P. EKSTRÖM, L.‐H. ENANDER, O. FAUSA, T. LIND, H. LÖNROTH, S. SANDMARK, B. SANDZÉN, P. UNGE & I. H. WESTIN. (2007) Omepmazole or high‐dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’of H 2 ‐receptor antagonists . Alimentary Pharmacology & Therapeutics 4:2, pages 145-155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.